| Shareholder | |||||
|---|---|---|---|---|---|
Harbin Pharmaceutical Group Co., Ltd. | 74.63% | 432.76M | 0.20% | -1.13M | |
Hong Kong Exchanges and Clearing Limited | 0.86% | 5.02M | 0.20% | +1.16M | |
UBS Asset Management AG | 0.29% | 1.71M | 0.23% | +1.32M | |
Vanguard Capital Management, LLC | 0.23% | 1.33M | 0.03% | +160.10K | |
China International Capital Corporation Hong Kong Asset Management Limited | 0.18% | 1.06M | 0.00% | +0 | |
The Goldman Sachs Group, Inc. | 0.15% | 850.58K | 0.06% | +358.19K | |
GF Fund Management Co., Ltd. | 0.13% | 731.55K | 0.00% | +0 | |
Morgan Stanley | 0.11% | 630.01K | 0.03% | -173.14K | |
Beijing Jin'an Private Fund Management Co., Ltd. | 0.10% | 600.10K | 0.00% | +0 | |
Huatai-PineBridge Fund Management Co., Ltd. | 0.10% | 582.70K | -- | +582.70K | |
Vanguard Investments Australia Limited | 0.07% | 407.23K | -- | +0 | |
Zhong Ou Fund Management Co., Ltd | 0.06% | 356.30K | 0.00% | +0 | |
China Asset Management Co. Ltd. | <0.01% | 17.70K | 0.00% | +0 | |
Fullgoal Fund Management Co. Ltd. | <0.01% | 17.00K | 0.00% | +0 | |
Ping An UOB Fund Management Co., Ltd. | <0.01% | 2.10K | 0.00% | +0 |
